NEW YORK (GenomeWeb) – Invitae and TME Research said today that they have begun a new clinical collaboration in which they plan to evaluate the benefits of universal genetic testing of breast cancer patients.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.